Literature DB >> 7988204

Epigallocatechin gallate. The major causative agent of green tea-induced asthma.

T Shirai1, A Sato, Y Hara.   

Abstract

We describe three patients who worked in green tea factories and developed asthmatic and nasal symptoms after exposure to green tea dust. To clarify what component(s) of green tea leaves might be responsible for causing asthma, we prepared catechins, the major components of green tea leaves. Epigallocatechin gallate (EGCg; MW: 458 daltons), a major catechin, was purified by high-performance liquid chromatography. Subjects included three patients with green tea-induced asthma, five asthmatics with no previous exposure to tea dust, and five healthy controls. It was found that all three patients exhibited an immediate skin and bronchial response to EGCg. Prausnitz-Küstner test with EGCg was also positive. However, none of the asthmatic and healthy controls showed a positive reaction. These results indicate that EGCg is a causative agent of green tea-induced asthma and suggest that an IgE-mediated response is, at least in part, responsible for causing this type of occupational asthma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988204     DOI: 10.1378/chest.106.6.1801

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Fourteen-week toxicity study of green tea extract in rats and mice.

Authors:  Po C Chan; Yuval Ramot; David E Malarkey; Pamela Blackshear; Grace E Kissling; Greg Travlos; Abraham Nyska
Journal:  Toxicol Pathol       Date:  2010-09-30       Impact factor: 1.902

2.  Effect of epigallocatechin gallate supplementation in schizophrenia and bipolar disorder: an 8-week, randomized, double-blind, placebo-controlled study.

Authors:  Jennifer M Loftis; Clare J Wilhelm; Marilyn Huckans
Journal:  Ther Adv Psychopharmacol       Date:  2013-02

3.  Occupational hypersensitivity pneumonitis in a green tea manufacturer.

Authors:  Yuko Tanaka; Toshihiro Shirai; Noriyuki Enomoto; Kazuhiro Asada; Yoshiyuki Oyama; Takafumi Suda
Journal:  Respirol Case Rep       Date:  2016-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.